Jump to content

CBN

From Pharmacopedia
Revision as of 06:22, 19 May 2026 by MDElliottMD (talk | contribs) (Create Cannabinol (CBN) medicine stub: minor phytocannabinoid, THC oxidation product, weak CB1 partial agonist, popularly framed as a sleep cannabinoid with sparse controlled evidence. Cites Russo 2011 entourage-effect review (PMID 21749363).)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

This page is only a stub and has not yet been reviewed. Any and all facts within are questionable. Please feel free to fill in gaps where you know how to fill them by editing this page.

Cannabinoid (minor), phytocannabinoid, THC oxidation product
Cannabinol
Cannabinol (CBN) is a minor phytocannabinoid present in small concentrations in fresh cannabis and accumulating in stored, oxidized, or heat-degraded plant material as a non-enzymatic oxidation product of delta-9-tetrahydrocannabinol. It binds the CB1 receptor with roughly one-tenth the affinity of THC and is at most very weakly psychoactive on its own. CBN is often described in popular sources as a "sleep cannabinoid", but the controlled evidence for a hypnotic effect is sparse; the sedation associated with old or degraded cannabis is more likely the combined contribution of CBN, other oxidation products, and shifts in terpene profile than CBN alone.[1]

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Cannabinoid (minor), phytocannabinoid, THC oxidation product
Common uses
Pharmacy
Pharmacology
Purported mechanism
Weak CB1 partial agonist; weak CB2 partial agonist; multiple secondary targets.
  1. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug;163(7):1344-64. PMID: 21749363.